Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.
A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.
Startup Colossal Biosciences has edited the DNA of a gray wolf to produce what it says is a de-extincted animal. Does that make it a true dire wolf?
In an advance for treating male infertility, researchers transplanted a patient with his own sperm-forming stem cells that were collected from testicular tissue when he was a child.
The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical disabilities to have more natural interactions with the world around them.
The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.
The de-extinction company Colossal Biosciences wants to bring back the woolly mammoth—starting with a very furry mouse.
Biohacker Josie Zyner’s new company, Los Angeles Project, is creating a new generation of gene-edited pets.
Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are capable of decoding what they smell.
The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to help treat victims of traumatic injuries.